| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/27/2009 | EP2061505A2 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 05/27/2009 | EP2061494A1 Regulation of expression of p140cap protein in tumors |
| 05/27/2009 | EP2061493A1 Compositions to reduce or prevent skin cancer |
| 05/27/2009 | EP2061482A1 Method of modulation of expression of epidermal growth factor receptor (egfr) involving mirna |
| 05/27/2009 | EP2061479A2 Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof |
| 05/27/2009 | EP2061464A2 Combination therapy for tumoral disease treatment |
| 05/27/2009 | EP2061453A2 2,5-dihydroxybenzene compounds for treating cancers and hematological dyscrasias |
| 05/27/2009 | EP2061452A2 Anti cancer use of caffeic acid and derivatives |
| 05/27/2009 | EP2061451A2 Bis(thiohydrazide amides) for treating melanoma |
| 05/27/2009 | EP1981874B1 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 05/27/2009 | EP1960403B1 Pyrrolotriazine kinase inhibitors |
| 05/27/2009 | EP1807419B1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/27/2009 | EP1789107B1 Medical stent provided with inhibitors of atp synthesis |
| 05/27/2009 | EP1740173A4 Azabicyclo-octane inhibitors of iap |
| 05/27/2009 | EP1663241B1 5-arylpyrimidines as anticancer agents |
| 05/27/2009 | EP1594497B1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| 05/27/2009 | EP1548032B1 Kdr peptides and vaccines comprising the same |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1509246B1 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1250140B1 Combination ofan abl-, pdgf-receptor- and/or kit receptor-tyrosine kinase inhibitor with an organic compound capable of binding to alpha1-acidic glycoprotein |
| 05/27/2009 | EP1222174B1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
| 05/27/2009 | EP1200476B1 Antitumor antibodies, proteins, and uses thereof |
| 05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/27/2009 | EP0871487B1 Dendritic cell stimulatory factor |
| 05/27/2009 | CN101443359A Antibodies to EGFL7 and methods for their use |
| 05/27/2009 | CN101443340A Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use |
| 05/27/2009 | CN101443335A Thiazolyl dihydro-indazoles |
| 05/27/2009 | CN101443333A 36 -des (3 -methoxy-4 -hydroxycyclohexyl) 36 - (3 -hydroxycycloheptyl) derivatives of rapamycin for the treatment of cancer and other disorders |
| 05/27/2009 | CN101443331A Triazolopyrazine derivatives useful as anti-cancer agents |
| 05/27/2009 | CN101443325A 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors |
| 05/27/2009 | CN101443316A 1,5-diphenylpyrazoles II as HSP90 inhibitors |
| 05/27/2009 | CN101443027A Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells |
| 05/27/2009 | CN101443024A Plant extract and preparation method and use thereof |
| 05/27/2009 | CN101443017A Medication against breast cancer and related diseases |
| 05/27/2009 | CN101443016A Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
| 05/27/2009 | CN101443014A Chemical compounds |
| 05/27/2009 | CN101443009A Antitumor agent for thyroid cancer |
| 05/27/2009 | CN101443003A Triazole derivatives II |
| 05/27/2009 | CN101443002A Combination comprising an iron chelator and an anti-neoplastic agent and use thereof |
| 05/27/2009 | CN101442999A Borrelidin derivatives as antiproliferative agents and angiogenesis inhibitors |
| 05/27/2009 | CN101442995A Novel actives against prostate carcinoma |
| 05/27/2009 | CN101442994A Method and compositions for treating hematological malignancies |
| 05/27/2009 | CN101440379A Obtaining method and use of novel oncolytic adenovirus construct with selective tumor blockage STAT3 |
| 05/27/2009 | CN101440378A Construction scheme and use of recombinant adeno related virus containing 16 type HPV antisense E7 gene |
| 05/27/2009 | CN101440355A Enterobacter cloacae, and use of polysaccharide and polysaccharide thereof |
| 05/27/2009 | CN101440130A Variable regions of heavy chain and light chain of antihuman IL-13R alpha 2 monoclonal antibody |
| 05/27/2009 | CN101440126A Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 05/27/2009 | CN101440119A Novel antineoplastic compound Holothuria nobilis Selenka saponin B in Holothuria nobilis Selenka |
| 05/27/2009 | CN101440118A Saponin compound extracted from Momordica grosvenori root, preparation and use thereof |
| 05/27/2009 | CN101440111A Anti-tumor compound and preparation thereof |
| 05/27/2009 | CN101440097A 1-(3',4',5'- trisubstituted phenyl)- isoquinoline compound and medical use thereof |
| 05/27/2009 | CN101440096A 1-(3',4',5'- trisubstituted phenyl)- tetrahydroisoquinoline compound and its use |
| 05/27/2009 | CN101440092A 2-indazole-4-aza indole-5-amino derivatives, and preparation and use thereof |
| 05/27/2009 | CN101440086A Halogenated pyrrole substituted indolinones, and intermediate, preparation and use thereof |
| 05/27/2009 | CN101440073A Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof |
| 05/27/2009 | CN101440064A Aconite napelline type diterpene alkaloid acylate, synthesis and use thereof |
| 05/27/2009 | CN101440029A Method for extracting xanthohumol from lupulus |
| 05/27/2009 | CN101439189A Use of zebra fish Caspy2 gene in preparing medicament for treating tumor |
| 05/27/2009 | CN101439188A Polymer lyophilized preparation of insoluble anti-tumor medicament |
| 05/27/2009 | CN101439185A Method for preparing composite preparation for treating lung cancer |
| 05/27/2009 | CN101439182A Somatostatin receptor mediated tumor-targeted medicament composition |
| 05/27/2009 | CN101439174A Chinese medicine prescription for treating non-small cell lung cancer |
| 05/27/2009 | CN101439160A Use of corn extract for preventing and treating tumor |
| 05/27/2009 | CN101439147A Haiqihuang granules as well as preparation method thereof and pharmacy use |
| 05/27/2009 | CN101439067A Chinese medicine granular containing ginseng extract and preparation method thereof |
| 05/27/2009 | CN101439056A Technique for preparing Tremella fuciformis spores polysaccharide soft capsules |
| 05/27/2009 | CN101439055A Use of aqueous extract of Trametes robiniophila Murr. in preparing medicament |
| 05/27/2009 | CN101439050A Medicament for treating malignancy and production method |
| 05/27/2009 | CN101439043A Teniposide injection and preparation method thereof |
| 05/27/2009 | CN101439042A Anti-tumor use of isoamylene flavonoid glycoside |
| 05/27/2009 | CN101439033A Polyenic taxusol lipid complexes and micelle composition thereof for injection |
| 05/27/2009 | CN101439032A Paclitaxel lipid complexes and micelle composition thereof for injection |
| 05/27/2009 | CN101439025A Silymarin high-efficient long-acting preparation and production method thereof |
| 05/27/2009 | CN101439020A Polyenic taxusol nano lipid carrier and preparation method thereof |
| 05/27/2009 | CN101439019A Paclitaxel nano lipid carrier and preparation method thereof |
| 05/27/2009 | CN101439017A Method for preparing polymer aqueous solution formulation of taxane anti-tumor medicament |
| 05/27/2009 | CN101439016A Bendamustine and potentiating agent thereof carried by anti-cancer medicine sustained-release injection |
| 05/27/2009 | CN100491398C Method of manufacturing human antibody possessing bioreceptor synergist, antagonist and/or inverse synergist |
| 05/27/2009 | CN100491394C Anti-angiogenic polypeptides |
| 05/27/2009 | CN100491389C Sialic combined immunoglobulin like agglutinin inhibitors |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491372C Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491370C Sulfamate benzothiophene ester derivatives as steroid sulfatase inhibitors |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491363C C7 ester-substituted taxane |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100491360C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 05/27/2009 | CN100491358C Pyrimidinone compounds, compositions and methods |
| 05/27/2009 | CN100491354C Quinoline kind iriyellowsin electronic isostere and its preparation process and use |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100490903C Oligonucleotide for targeted activation of chronic granulocyte leukaemia protein kinase PKR and application thereof |
| 05/27/2009 | CN100490902C Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 05/27/2009 | CN100490899C Pharmaceutical compositions |
| 05/27/2009 | CN100490895C CD40-binding APC-activating molecules |
| 05/27/2009 | CN100490876C Sarcadra injection, its making method and venous injection |
| 05/27/2009 | CN100490850C Application of magnolia vine fruit in preparation of anti-tumor medicine or multi-medicine tolerant reversal agent |